Lipid profile associated with antiretroviral use

With the progression of AIDS caused by HIV, antiretroviral therapies have been developed to reduce plasma viremia, resulting in effective treatment of HIV carriers. The introduction of high-potency antiretroviral therapy, resulting from the combination of different drugs with different targets, represented an alternative that significantly reduced complications resulting from the infection and increased the life expectancy of those infected. However, other complications associated with antiretroviral drugs have been highlighted, such as changes in lipid metabolism and consequent cardiovascular disorders. The aim of this study was to describe the effect of antiretroviral drugs on the lipid profile of HIV-infected patients attending the STD/AIDS programme in the municipality of Gurupi, Tocantins.